Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa Bay news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Charlotte news in your inbox

Catch up on the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sam Jayne / Axios

Hospitals and health care companies often flood email inboxes and wire services with press releases that tout new procedures or devices. The marketing intent is clear — they want to attract patients to their facilities or get the word out on their new technology.

The one thing they don't talk about: the price.

Why it matters: Adopting new technologies contributes a lot to the growth of health care spending. To battle that growth, the health care industry promotes price transparency as a way to encourage competition and lower spending. However, most hospitals and providers really don't embrace price transparency, and continue to advertise the latest procedures with seemingly little regard for costs.

The Sharp Coronado Hospital case: This past July, Sharp Coronado Hospital in California issued a press release that proclaimed it was the "first hospital in the U.S. to perform a general surgery procedure using the new da Vinci X Robotic Surgical System," which is made by Intuitive Surgical. A local NBC affiliate ran with the story, which could be mistaken for a rewritten press release.

Many other hospital systems have boasted about having Intuitive Surgical's robots, which has led to a surgical arms race over the past decade.

Unmentioned in the latest release:

  • The hospital's list price of the robotic surgical procedure (this is what uninsured people would pay).
  • The costs an insured patient would have to pay out of pocket.

Both are still unknown. Tom Hanscom, a Sharp Coronado spokesman, said the list price would be provided if someone makes a formal request for the procedure. And because there are so many different insurance plans (and because private rates are often under gag clauses), he said it's impossible to give a broad number of what the procedure would cost.

"Our intent with the press release was to simply announce we have this new technology at our hospital to treat our patients and nothing beyond that," Hanscom said.

The NYU Winthrop Hospital case: NYU Winthrop Hospital in New York provided the most transparency of the multiple organizations that were contacted. The hospital recently advertised a prostate implant called UroLift. A spokesman said Medicare paid about $1,200 for the initial implant and $900 for each additional one. Commercial rates are proprietary and depend on a patient's copay, coinsurance or deductible, the spokesman said.

Reality check: Price transparency tools are barely used by most people and won't drastically reduce health care spending. Hospitals also don't really want to give out prices or costs even though the Affordable Care Act requires hospitals to inform the public about their charges.

"You're shopping with a blindfold on," said Gerard Anderson, a health policy expert at Johns Hopkins University. "You're shopping with not having both the pricing information and the value information that you need to be an informed shopper."

Press releases about new technologies are just as likely intended to catch the attention of doctors. "You're also not the person typically making the choice," Anderson said. "It's the doctor making the choice on your behalf."

That's not all: The safety and value of technologies that are being heralded are just as vital. Producing and searching for new devices and procedures is a good thing, Anderson said, but the technology should be more than an advertising gimmick and provide more than just a marginal benefit to patients.

Go deeper

Trump political team disavows "Patriot Party" groups

Marine One carries President Trump away from the White House on Inauguration Day. Photo: Patrick Smith/Getty Images

Donald Trump's still-active presidential campaign committee officially disavowed political groups affiliated with the nascent "Patriot Party" on Monday.

Why it matters: Trump briefly floated the possibility of creating a new political party to compete with the GOP — with him at the helm. But others have formed their own "Patriot Party" entities during the past week, and Trump's team wants to make clear it has nothing to do with them.

DOJ watchdog to probe whether officials sought to alter election results

Donald and Melania Trump exit Air Force One in West Palm Beach, Fla., on Jan. 20. Photo: Alex Edelman/AFP via Getty Images

The Justice Department's inspector general will investigate whether any current or former DOJ officials "engaged in an improper attempt to have DOJ seek to alter the outcome" of the 2020 election, the agency announced Monday.

Driving the news: The investigation comes in the wake of a New York Times report that alleged Jeffrey Clark, the head of DOJ's civil division, had plotted with President Trump to oust acting Attorney General Jeffery Rosen in a scheme to overturn the election results in Georgia.